{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=omeprazole%2Fsodium+bicarbonate", "query": { "intervention": "omeprazole/sodium bicarbonate" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T15:19:48.245Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00693225", "title": "Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Erosive Esophagitis" ], "interventions": [ { "name": "Omeprazole/sodium bicarbonate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Yvonne Romero", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 91, "start_date": "2008-01", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2012-09-20", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT00693225" }, { "nct_id": "NCT01129778", "title": "Assessment of Zegerid on Esophageal pH in Patients With Barrett's Esophagus", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Barrett Esophagus", "Gastroesophageal Reflux" ], "interventions": [ { "name": "Zegerid (proton pump inhibitor)", "type": "DRUG" }, { "name": "Bravo pH monitoring", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 27, "start_date": "2009-11", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2017-06-06", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01129778" }, { "nct_id": "NCT00001337", "title": "Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Diffuse Large B-Cell Lymphoma (DLBCL)", "Primary Mediastinal Large B-cell Lymphoma", "Burkitt Lymphoma", "Anaplastic Large-Cell Lymphoma", "Gray Zone Lymphoma" ], "interventions": [ { "name": "Etoposide", "type": "DRUG" }, { "name": "Rituximab", "type": "BIOLOGICAL" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Vincristine", "type": "DRUG" }, { "name": "Doxorubicin", "type": "DRUG" }, { "name": "MRI", "type": "DIAGNOSTIC_TEST" }, { "name": "CT", "type": "DIAGNOSTIC_TEST" }, { "name": "Biopsy", "type": "PROCEDURE" }, { "name": "PET scan", "type": "DIAGNOSTIC_TEST" }, { "name": "Laparotomy", "type": "PROCEDURE" }, { "name": "Ondansetron", "type": "OTHER" }, { "name": "Prochlorperazine", "type": "OTHER" }, { "name": "Omeprazole", "type": "OTHER" }, { "name": "Docusate Sodium + Sennosides", "type": "OTHER" }, { "name": "Lactulose", "type": "OTHER" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "DIAGNOSTIC_TEST", "PROCEDURE", "OTHER" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 348, "start_date": "1993-05-08", "completion_date": "2024-05-24", "has_results": true, "last_update_posted_date": "2025-06-22", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 5, "location_summary": "Fort Lauderdale, Florida • Baltimore, Maryland • Bethesda, Maryland + 2 more", "locations": [ { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00001337" }, { "nct_id": "NCT03100838", "title": "Drug Interaction With Proton Pump Inhibitors for Nifedipine ER Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Nifedipine 60 MG Extended Release Oral Tablet", "type": "DRUG" }, { "name": "omeprazole/sodium bicarbonate", "type": "DRUG" }, { "name": "SmartPill (TM)", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Food and Drug Administration (FDA)", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 64, "start_date": "2017-03-20", "completion_date": "2018-04-06", "has_results": true, "last_update_posted_date": "2019-08-16", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT03100838" }, { "nct_id": "NCT00978016", "title": "A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastroesophageal Reflux Disease" ], "interventions": [ { "name": "arbaclofen placarbil-Cohort 1", "type": "DRUG" }, { "name": "Placebo-Cohort 5", "type": "DRUG" }, { "name": "arbaclofen placarbil-Cohort 2", "type": "DRUG" }, { "name": "arbaclofen placarbil-Cohort 3", "type": "DRUG" }, { "name": "arbaclofen placarbil-Cohort 4", "type": "DRUG" }, { "name": "PPI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "XenoPort, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 460, "start_date": "2009-09", "completion_date": "2010-12", "has_results": false, "last_update_posted_date": "2021-02-21", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 62, "location_summary": "Huntsville, Alabama • Chandler, Arizona • Mesa, Arizona + 56 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00978016" }, { "nct_id": "NCT00808769", "title": "Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Normal Healthy Subject Population" ], "interventions": [ { "name": "Zegerid®", "type": "DRUG" }, { "name": "Prilosec OTC®", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Procter and Gamble", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 30, "start_date": "2008-11", "completion_date": "2008-12", "has_results": true, "last_update_posted_date": "2015-06-01", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT00808769" }, { "nct_id": "NCT00557349", "title": "Ulcer Prevention Study in Post Gastric Bypass Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Marginal Ulcers" ], "interventions": [ { "name": "Omeprazole", "type": "DRUG" }, { "name": "Famotidine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 40, "start_date": "2006-11", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2017-01-19", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00557349" }, { "nct_id": "NCT02922933", "title": "A Study to Examine the Effect of Omeprazole, Famotidine, and an Acidic Beverage on the Pharmacokinetics of Entinostat in Healthy Adult Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Volunteers", "Healthy Volunteers", "Human Volunteers", "Normal Volunteers" ], "interventions": [ { "name": "entinostat", "type": "DRUG" }, { "name": "Omeprazole", "type": "DIETARY_SUPPLEMENT" }, { "name": "Famotidine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DRUG", "DIETARY_SUPPLEMENT" ], "sponsor": "Syndax Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "19 Years to 55 Years" }, "enrollment_count": 66, "start_date": "2016-10-25", "completion_date": "2017-05-08", "has_results": false, "last_update_posted_date": "2018-08-16", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 2, "location_summary": "Tempe, Arizona • Lincoln, Nebraska", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Lincoln", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT02922933" }, { "nct_id": "NCT01661101", "title": "Management of Myocardial Injury After Noncardiac Surgery Trial", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Myocardial Injury After Noncardiac Surgery (MINS)" ], "interventions": [ { "name": "Dabigatran", "type": "DRUG" }, { "name": "Placebo (for Dabigatran)", "type": "DRUG" }, { "name": "Omeprazole", "type": "DRUG" }, { "name": "Placebo (for Omeprazole)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Population Health Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 1754, "start_date": "2013-01", "completion_date": "2018-03-01", "has_results": false, "last_update_posted_date": "2018-03-26", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 7, "location_summary": "Kansas City, Kansas • Buffalo, New York • Rochester, New York + 4 more", "locations": [ { "city": "Kansas City", "state": "Kansas" }, { "city": "Buffalo", "state": "New York" }, { "city": "Rochester", "state": "New York" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT01661101" }, { "nct_id": "NCT00045799", "title": "Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Upper Gastrointestinal Bleeding" ], "interventions": [ { "name": "Omeprazole sodium bicarbonate immediate release PWD/FS", "type": "DRUG" }, { "name": "Cimetidine IV", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch Health Americas, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "ALL", "summary": "16 Years and older" }, "enrollment_count": 354, "start_date": "2002-05", "completion_date": "2003-05", "has_results": false, "last_update_posted_date": "2019-11-25", "last_synced_at": "2026-09-26T15:19:48.245Z", "location_count": 58, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 49 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00045799" } ] }